These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 15218415

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Deoxycholate amphotericin B and nephrotoxicity in the pediatric setting.
    Bes DF, Rosanova MT, Sberna N, Arrizurieta E.
    Pediatr Infect Dis J; 2014 Aug; 33(8):e198-206. PubMed ID: 24618932
    [Abstract] [Full Text] [Related]

  • 3. Amphotericin B nephrotoxicity.
    Sabra R, Branch RA.
    Drug Saf; 1990 Aug; 5(2):94-108. PubMed ID: 2182052
    [Abstract] [Full Text] [Related]

  • 4. Are salt loading and prolonging infusion period effective in prevention of amphotericin B-induced nephrotoxicity?
    Karimzadeh I, Farsaei S, Khalili H, Dashti-Khavidaki S.
    Expert Opin Drug Saf; 2012 Nov; 11(6):969-83. PubMed ID: 22950480
    [Abstract] [Full Text] [Related]

  • 5. Role of humoral mediators in, and influence of a liposomal formulation on, acute amphotericin B nephrotoxicity.
    Sabra R, Zeinoun N, Sharaf LH, Ghali R, Beshara G, Serhal H.
    Pharmacol Toxicol; 2001 Apr; 88(4):168-75. PubMed ID: 11322173
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms and management of amphotericin B-induced nephrotoxicity.
    Miano-Mason TM.
    Cancer Pract; 1997 Apr; 5(3):176-81. PubMed ID: 9171554
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients.
    Gubbins PO, Penzak SR, Polston S, McConnell SA, Anaissie E.
    Pharmacotherapy; 2002 Aug; 22(8):961-71. PubMed ID: 12173799
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study.
    Falci DR, da Rosa FB, Pasqualotto AC.
    Mycoses; 2015 Feb; 58(2):104-12. PubMed ID: 25590436
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Liposomal amphotericin B: a unique pharmacokinetic profile. An unfinished story].
    Azanza Perea JR, Barberán J.
    Rev Esp Quimioter; 2012 Mar; 25(1):17-24. PubMed ID: 22488537
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Lipid formulations of polyene antifungal drugs and attenuation of associated nephrotoxicity.
    Razzaque MS, Hossain MA, Ahsan N, Taguchi T.
    Nephron; 2001 Nov; 89(3):251-4. PubMed ID: 11598385
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations.
    Andrew EC, Curtis N, Coghlan B, Cranswick N, Gwee A.
    Br J Clin Pharmacol; 2018 May; 84(5):1006-1012. PubMed ID: 29352486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.